Common Contracts
2 similar Confidential Settlement Agreement contracts by Biosante Pharmaceuticals Inc
ContractConfidential Settlement Agreement • May 5th, 2020
EX-10.2 2 settlement.htm SETTLEMENT AGREEMENT AS AMENDED CONFIDENTIAL SETTLEMENT AGREEMENT WHEREAS, the Parties to this Confidential Settlement Agreement (this “Agreement”) are Leah Lehman (“Lehman”), BioSante Pharmaceuticals, Inc. (“BioSante”), BioSante’s Vice Chairman, President and Chief Executive Officer Stephen M. Simes (“Simes”), BioSante’s Chief Financial Officer, Treasurer and Secretary Phillip Donenberg (“Donenberg”), and Victor Morgenstern, a BioSante director (“Morgenstern” and, together with Lehman, BioSante, Simes and Donenberg, sometimes referred to herein collectively as the “Parties”); WHEREAS, Lehman was employed by BioSante in accordance with the provisions of an Employment Agreement dated December 15, 2000 (the “Employment Agreement,” a true copy of which is appended as Appendix 1); WHEREAS, certain disputes have arisen concerning that employment, events allegedly occurring during the time of that employment, whether within the scope of her employment or otherwise, a
CONFIDENTIAL SETTLEMENT AGREEMENTConfidential Settlement Agreement • August 14th, 2006 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
WHEREAS, the Parties to this Confidential Settlement Agreement (this “Agreement”) are Leah Lehman (“Lehman”), BioSante Pharmaceuticals, Inc. (“BioSante”), BioSante’s Vice Chairman, President and Chief Executive Officer Stephen M. Simes (“Simes”), BioSante’s Chief Financial Officer, Treasurer and Secretary Phillip Donenberg (“Donenberg”), and Victor Morgenstern, a BioSante director (“Morgenstern” and, together with Lehman, BioSante, Simes and Donenberg, sometimes referred to herein collectively as the “Parties”);
